Arrowhead Pharmaceuticals, Inc. (ARWR)

Last Closing Price: 16.07 (2025-05-30)

Weighted-Average Shares Outstanding (Diluted) (Quarterly)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Arrowhead Pharmaceuticals, Inc. (ARWR) had Weighted-Average Shares Outstanding (Diluted) of 134.48M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$542.71M
$370.44M
--
$542.71M
$161.51M
$381.20M
$-11.59M
$369.62M
$369.62M
$367.86M
$367.86M
$367.86M
$367.86M
$381.20M
$390.20M
133.36M
Weighted-Average Shares Outstanding (Diluted)
134.48M
$2.78
$2.75
Balance Sheet Financials
$1.14B
$384.80M
$438.28M
$1.57B
$220.54M
$208.93M
$668.73M
$889.27M
$684.23M
$676.51M
$684.23M
138.06M
Cash Flow Statement Financials
$313.78M
$-343.30M
$113.02M
$102.69M
$185.71M
$83.02M
$31.24M
--
--
Fundamental Metrics & Ratios
5.15
--
--
0.23
0.40
100.00%
70.24%
70.24%
--
68.11%
68.26%
$300.97M
--
--
--
0.34
--
229.48
0.39
53.76%
54.38%
23.38%
41.19%
$4.96
$2.24
$2.33